Pepdox
Studies
Peptides
Calculator
In adults with moderate-to-severe OSA and obesity, tirzepatide reduced apnea-hypopnea events vs. placebo. | Pepdox
Home
/
Search
/
PMID 39348697
In adults with moderate-to-severe OSA and obesity, tirzepatide reduced apnea-hypopnea events vs. placebo.
Annals of internal medicine
2024
PMID: 39348697
View on PubMed
DOI: 10.7326/ANNALS-24-02174-JC
Tirzepatide
Abstract
Malhotra A, Grunstein RR, Fietze I, et al; SURMOUNT-OSA Investigators.N Engl J Med. 21 Jun 2024. [Epub ahead of print.] 38912654.
Authors
Cheskin, Lawrence J; Rajagopal, Selvi